Clinical Trials Browser

Not yet recruiting × Klatskin Tumor × Gemcitabine × Clear all

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06923475 2025-04-11

NEODISCO

Phase 2/3 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor